These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 25222764

  • 1. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
    Xie L, Frech-Tamas F, Marrett E, Baser O.
    Curr Med Res Opin; 2014 Dec; 30(12):2415-22. PubMed ID: 25222764
    [Abstract] [Full Text] [Related]

  • 2. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial.
    Sung J, Ahn KT, Cho BR, Lee SY, Kim BJ, Kim DK, Park JI, Lee WS.
    Clin Transl Sci; 2021 May; 14(3):1185-1192. PubMed ID: 33503302
    [Abstract] [Full Text] [Related]

  • 3. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
    Machnicki G, Ong SH, Chen W, Wei ZJ, Kahler KH.
    Curr Med Res Opin; 2015 Dec; 31(12):2287-96. PubMed ID: 26397178
    [Abstract] [Full Text] [Related]

  • 4. Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.
    Kreutz R, Scholze J, Douros A.
    Curr Vasc Pharmacol; 2018 Jan 26; 16(2):197-203. PubMed ID: 28828980
    [Abstract] [Full Text] [Related]

  • 5. Single-pill triple-combination therapy: an alternative to multiple-drug treatment of hypertension.
    Chrysant SG.
    Postgrad Med; 2011 Nov 26; 123(6):21-31. PubMed ID: 22104451
    [Abstract] [Full Text] [Related]

  • 6. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Nov 26; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 7. Triple-drug, fixed-dose combinations for the treatment of hypertension: focus on olmesartan/amlodipine/hydrochlorothiazide combination.
    Chrysant SG.
    Drugs Today (Barc); 2011 Mar 26; 47(3):197-206. PubMed ID: 21494697
    [Abstract] [Full Text] [Related]

  • 8. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA, Chapman RH, Benner JS, Tang SS, Solomon HA, Joyce A, Foody JM.
    Am J Cardiovasc Drugs; 2010 Mar 26; 10(3):193-202. PubMed ID: 20387911
    [Abstract] [Full Text] [Related]

  • 9. Patient Adherence to Olmesartan/Amlodipine Combinations: Fixed Versus Extemporaneous Combinations.
    Levi M, Pasqua A, Cricelli I, Cricelli C, Piccinni C, Parretti D, Lapi F.
    J Manag Care Spec Pharm; 2016 Mar 26; 22(3):255-62. PubMed ID: 27003555
    [Abstract] [Full Text] [Related]

  • 10. Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy.
    Borghi C, Jayagopal PB, Konradi A, Bortolotto LA, Degli Esposti L, Perrone V, Snyman JR.
    Adv Ther; 2023 Apr 26; 40(4):1765-1772. PubMed ID: 36829102
    [Abstract] [Full Text] [Related]

  • 11. Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study.
    Sison J, Assaad-Khalil SH, Najem R, Kitchlew AR, Cho B, Ueng KC, Shete A, Knap D.
    Curr Med Res Opin; 2014 Oct 26; 30(10):1937-45. PubMed ID: 25007309
    [Abstract] [Full Text] [Related]

  • 12. Pill burden in hypertensive patients treated with single-pill combination therapy--an observational study.
    Hagendorff A, Freytag S, Müller A, Klebs S.
    Adv Ther; 2013 Apr 26; 30(4):406-19. PubMed ID: 23532555
    [Abstract] [Full Text] [Related]

  • 13. Long-term persistence with single-pill, fixed-dose combination therapy versus two pills of amlodipine and perindopril for hypertension: Australian experience.
    Simons LA, Chung E, Ortiz M.
    Curr Med Res Opin; 2017 Oct 26; 33(10):1783-1787. PubMed ID: 28805468
    [Abstract] [Full Text] [Related]

  • 14. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
    Jackson KC, Sheng X, Nelson RE, Keskinaslan A, Brixner DI.
    Clin Ther; 2008 Aug 26; 30(8):1558-63. PubMed ID: 18803997
    [Abstract] [Full Text] [Related]

  • 15. Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study.
    Lauffenburger JC, Landon JE, Fischer MA.
    J Gen Intern Med; 2017 Jun 26; 32(6):619-625. PubMed ID: 28050754
    [Abstract] [Full Text] [Related]

  • 16. Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation.
    Derosa G, Cicero AF, Carbone A, Querci F, Fogari E, D'Angelo A, Maffioli P.
    Eur J Pharm Sci; 2014 Jan 23; 51():26-33. PubMed ID: 23999037
    [Abstract] [Full Text] [Related]

  • 17. Effects of valsartan versus olmesartan addition to amlodipine/hydrochlorothiazide combination in treating stage 2 hypertensive patients.
    Fogari R, Zoppi A, Mugellini A, Preti P, Perrone T, Maffioli P, Derosa G.
    Expert Opin Pharmacother; 2012 Apr 23; 13(5):629-36. PubMed ID: 22372508
    [Abstract] [Full Text] [Related]

  • 18. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho B, Ueng KC, DiTommaso S, Shete A.
    Vasc Health Risk Manag; 2015 Apr 23; 11():71-8. PubMed ID: 25653536
    [Abstract] [Full Text] [Related]

  • 19. [Medication adherence with the fixed combination of ramipril and amlodipine].
    Simonyi G, Ferenci T.
    Orv Hetil; 2014 Nov 23; 155(47):1882-8. PubMed ID: 25403283
    [Abstract] [Full Text] [Related]

  • 20. Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients With Use of Single-Pill Combinations: Results From the START-Study.
    Schmieder RE, Wassmann S, Predel HG, Weisser B, Blettenberg J, Gillessen A, Randerath O, Mevius A, Wilke T, Böhm M.
    Hypertension; 2023 May 23; 80(5):1127-1135. PubMed ID: 36987918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.